UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006186
Receipt number R000007318
Scientific Title The clinical study for effectiveness and safeness of levetiracetam combination therapy for symptomatic seizure
Date of disclosure of the study information 2011/09/01
Last modified on 2014/10/07 21:21:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The clinical study for effectiveness and safeness of levetiracetam combination therapy for symptomatic seizure

Acronym

The effectiveness of levetiracetam combination therapy

Scientific Title

The clinical study for effectiveness and safeness of levetiracetam combination therapy for symptomatic seizure

Scientific Title:Acronym

The effectiveness of levetiracetam combination therapy

Region

Japan


Condition

Condition

symptomatic intractable epilepsy

Classification by specialty

Neurosurgery Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The efficacy of combination therapy of levetilacetam for intractable epilepsy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

disppearace rate of attack
reduction rate of attack frequency

Key secondary outcomes

QOLIE-31


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Single blind -investigator(s) and assessor(s) are blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Medication of levetiracetum

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The intended patients which have symptomatic intractable epilepsy due to brain tumor,apoplexy and brain trauma.
they have already taken other existing other anti-epileptic drugs.

Key exclusion criteria

The pateints which can not be estimated the attack frequency during study peroid and with serious liver dysfunction, renal dysfunaction, severe brain vascular disease, brain tumor or metal disfunction.
A women with pregnacy or a possibility of pregnacy

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroyuki Kinouchi

Organization

Faculity of Meidison, Yamanashi Univiersity

Division name

Department of Neurosurgery

Zip code


Address

Shimokato1110, Chuo, Yamanashi

TEL

055-243-6786

Email

kawataki@yamanashi.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kawataki Tomoyuki

Organization

Faculity of Meidison, Yamanashi Univiersity

Division name

Department of Neurosurgery

Zip code


Address

Shimokato1110, Chuo, Yamanashi

TEL

055-243-6786

Homepage URL


Email

kawataki@yamanashi.ac.jp


Sponsor or person

Institute

Yamanashi Univiersity

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 07 Month 13 Day

Date of IRB


Anticipated trial start date

2011 Year 07 Month 01 Day

Last follow-up date

2012 Year 03 Month 01 Day

Date of closure to data entry

2014 Year 10 Month 07 Day

Date trial data considered complete

2014 Year 10 Month 07 Day

Date analysis concluded

2014 Year 10 Month 07 Day


Other

Other related information



Management information

Registered date

2011 Year 08 Month 17 Day

Last modified on

2014 Year 10 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007318


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name